6-Hydroxydopamine induces mitochondrial ERK activation

Free Radic Biol Med. 2007 Aug 1;43(3):372-83. doi: 10.1016/j.freeradbiomed.2007.04.028. Epub 2007 Apr 29.

Abstract

Reactive oxygen species (ROS) are implicated in 6-hydroxydopamine (6-OHDA) injury to catecholaminergic neurons; however, the mechanism(s) are unclear. In addition to ROS generated during autoxidation, 6-OHDA may initiate secondary cellular sources of ROS that contribute to toxicity. Using a neuronal cell line, we found that catalytic metalloporphyrin antioxidants conferred protection if added 1 h after exposure to 6-OHDA, whereas the hydrogen peroxide scavenger catalase failed to protect if added more than 15 min after 6-OHDA. There was a temporal correspondence between loss of protection and loss of the ability of the antioxidant to inhibit 6-OHDA-induced ERK phosphorylation. Time course studies of aconitase inactivation, an indicator of intracellular superoxide, and MitoSOX red, a mitochondria targeted ROS indicator, demonstrate early intracellular ROS followed by a delayed phase of mitochondrial ROS production, associated with phosphorylation of a mitochondrial pool of ERK. Furthermore, on initiation of mitochondrial ROS and ERK activation, 6-OHDA-injured cells became refractory to rescue by metalloporphyrin antioxidants. Together with previous studies showing that inhibition of the ERK pathway confers protection from 6-OHDA toxicity, and that phosphorylated ERK accumulates in mitochondria of degenerating human Parkinson's disease neurons, these studies implicate mitochondrial ERK activation in Parkinsonian oxidative neuronal injury.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Butadienes / pharmacology
  • Catalase / pharmacology
  • Cells, Cultured
  • Enzyme Activation
  • Extracellular Signal-Regulated MAP Kinases / physiology*
  • Flavonoids / pharmacology
  • Metalloporphyrins / pharmacology
  • Mitochondria / drug effects*
  • Mitochondria / physiology
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors
  • Neurons / drug effects
  • Nitriles / pharmacology
  • Oxidopamine / pharmacology*
  • Oxidopamine / toxicity
  • Rats
  • Signal Transduction

Substances

  • Butadienes
  • Flavonoids
  • Metalloporphyrins
  • Nitriles
  • U 0126
  • manganese (III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin
  • manganese(III)-tetrakis(4-benzoic acid)porphyrin
  • Oxidopamine
  • Catalase
  • Extracellular Signal-Regulated MAP Kinases
  • Mitogen-Activated Protein Kinase Kinases
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one